EQR
40
-2
F
40
-3
HIG
54
2
EOG
36
2
VMC
51
3
MOS
50
4
STZ
55
-3
AN
55
-2
GIS
34
-3
BXP
49
-3
M
50
-3
SLG
53
-2
DG
21
-6
SEE
48
-5
ADSK
67
2
CME
56
-3
RHI
59
2
AKAM
61
3
QCOM
55
4
FLR
52
4
EQR
40
-2
F
40
-3
HIG
54
2
EOG
36
2
VMC
51
3
MOS
50
4
STZ
55
-3
AN
55
-2
GIS
34
-3
BXP
49
-3
M
50
-3
SLG
53
-2
DG
21
-6
SEE
48
-5
ADSK
67
2
CME
56
-3
RHI
59
2
AKAM
61
3
QCOM
55
4
FLR
52
4
Financhill
Back

NeoGenomics 10K Form

Buy
71

NEO
NeoGenomics

Last Price:
17.89
Seasonality Move:
59.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-04-30 10Q NEO/NeoGenomics Quarterly
2024-02-20 10K NEO/NeoGenomics Annual
2023-11-06 10Q NEO/NeoGenomics Quarterly
2023-08-08 10Q NEO/NeoGenomics Quarterly
2023-05-09 10Q NEO/NeoGenomics Quarterly
2023-02-24 10K NEO/NeoGenomics Annual

Receive NEO News And Ratings

See the #1 stock for the next 7 days that we like better than NEO

NEO Financial Statistics

Sales & Book Value

Annual Sales: $591.64M
Cash Flow: $-1.55M
Price / Cash Flow: 0
Annual Sales: $7.09
Price / Book: 2.57

Profitability

EPS (TTM): -0.61000
Net Income (TTM): $-77.73M
Gross Margin: $244.6M
Return on Equity: -8.38%
Return on Assets: -4.69%

NeoGenomics Earnings Forecast

Key NeoGenomics Financial Ratios

  • The Gross Profit Margin over the past 24 years for NEO is 41.34%.
  • The Selling, General & Administrative Expenses for NEO have been equal to 53.06% of Gross Profit Margin.
  • The Research & Development expenses have been 4.62% of Revenue.
  • The Interest Expense is -7.85% of Operating Income.
  • The Net Earning history of NEO is -14.87% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 11 years.

NeoGenomics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: NEO
CUSIP: 64049M
Website: neogenomics.com

Debt

Debt-to-Equity Ratio: 0.6
Current Ratio: 1.99
Quick Ratio: 1.82

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 92.5

NEO Technical Analysis vs Fundamental Analysis

Buy
71
NeoGenomics (NEO) is a Buy

Is NeoGenomics a Buy or a Sell?

  • NeoGenomics stock is rated a Buy
    The current NeoGenomics [NEO] share price is $18.17. The Score for NEO is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.